David, Great analysis. I wasn't aware of the Windward publication articles. I'm assuming, based on the date, that the numbers quoted came from McMillan. That makes them more credible IMHO. I too ran the numbers. Pretty impressive at a P/E of 20 aren't they. Basically they are saying that starting this May they will have 16 million in sales 25% profit margin. Yearly revenues will double each year, with the fifth year producing 250 Million in Sales. If McMillian produce these results the stock will trade at a P/E much greater than 20. I'm not sure that any company/individual can accuratly look 5 years into the future, but they might be close on year 1 or 2 year estimate.
I talked to ICC on the recent correction. According to ICC there have been no fundemental changes within the last few weeks. ICC is very impressed with McMillian. They told me that they usually represent much larger companies, but made an exception, because of how impressed they were with him. I also requested an investors packet from them. This should provide answers to some of our questions.
There seems to be concern over the production of Novacrete, but I'm equally concerned about the distribution. Does anyone know if a distribution network is in place. Maybe the investor packet will tell.
I went back and read the history of this thread the other night. I noticed that Doug Friedenberg was one individual that was making inquiries similar to ours. (Great potential, but not quite sure about the product, sales, etc) I also noticed in a 13D Edgar filing showed that he had purchased 580,000 shares for approximately $174,000. Now he's on the board of directors. He must have got some good answers.
I'm sure that Doug can no longer participate in this discussion group, but it makes me feel better to know that someone has made such a major commitment to this company.
Doug if can you participate, please do. I'm sure your view of the company, and its prospects, would be greatly appreciated.
Mark S |